Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Larry Samuels

Showing results (1-10 of 3) with videos related to

Pageof 1
Sort By:
JAMA Network Open|January 19, 2021
Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical TrialNicole L Nollen, Jasjit S Ahluwalia, Lisa Sanderson Cox, et al.
The American Journal of Cardiology|December 7, 2010
Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials)Paul Frey, David D Waters, David A DeMicco, et al.
The Lancet. Child & Adolescent Health|September 27, 2020
High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trialKevin M Gray, Mark L Rubinstein, Judith J Prochaska, et al.
Pageof 1

Showing results (1-10 of 3) with videos related to

Sort By:
Pageof 1
JAMA Network Open|January 19, 2021
Assessment of Racial Differences in Pharmacotherapy Efficacy for Smoking Cessation: Secondary Analysis of the EAGLES Randomized Clinical TrialNicole L Nollen, Jasjit S Ahluwalia, Lisa Sanderson Cox, et al.
The American Journal of Cardiology|December 7, 2010
Impact of smoking on cardiovascular events in patients with coronary disease receiving contemporary medical therapy (from the Treating to New Targets [TNT] and the Incremental Decrease in End Points Through Aggressive Lipid Lowering [IDEAL] trials)Paul Frey, David D Waters, David A DeMicco, et al.
The Lancet. Child & Adolescent Health|September 27, 2020
High-dose and low-dose varenicline for smoking cessation in adolescents: a randomised, placebo-controlled trialKevin M Gray, Mark L Rubinstein, Judith J Prochaska, et al.
Pageof 1